Article
What is scheduled
HRSA revised its 340B Rebate Model Pilot Program in late July after a federal court blocked the first version days before its planned January 2026 launch. The new design lets qualifying manufacturers provide 340B pricing on a limited group of outpatient drugs through rebates rather than up-front discounts, and requires manufacturers to validate claims before paying. Manufacturers had until Aug. 24 to submit rebate plans, and approved plans take effect Jan. 1, 2027. HRSA argues the model improves claims-level transparency and helps prevent duplicate discounts.
The AHA told Congress on Sept. 23 that rebate models should be permanently barred. A separate bill, the SECURE 340B Act, would require up-front pricing for four years while a national claims clearinghouse is built.
What CEOs expect
In interviews published Sept. 28, hospital leaders described the operational effect. Genesis HealthCare System in Ohio offered an example: for a drug with a $12,000 wholesale price and a $7,000 340B price, the hospital pays $12,000 and waits for a $5,000 rebate. Its CEO expects to need one to two more full-time employees plus tracking technology. Nathan Littauer Hospital in upstate New York estimated at least one added employee at a minimum of $55,000 a year.
The sharpest warning came from Bristol Health in Connecticut, which has operated with less than 15 days cash on hand for three fiscal years. A January transition to up-front purchasing at wholesale acquisition cost created a $560,000 cash flow impact. The CEO estimated that a third-party rebate administrator could cost from $150,000 to more than $500,000, and said the system could cut services or cancel capital projects, including a labor and delivery renovation.
How to prepare
- Model the float. Estimate how much cash would be tied up between purchase and rebate for each likely drug, and how long rebates may take.
- Size the workload. Determine whether claims validation and rebate tracking will need new staff, a vendor or upgraded software.
- Check covenants. Confirm that a temporary drop in days cash on hand will not strain bond covenants or credit lines.
- Prepare data flows. Make sure pharmacy and billing systems can supply claims-level data quickly and accurately.
- Tell your story. Share specific dollar and staffing impacts with your congressional delegation while legislation is in play.
Archive entry for Sep 28, 2026, added Nov. 11, 2026.